Kovač, MD, PhD, V. (2014) “Intercalated chemotherapy and erlotinib for advanced NSCLC: high proportion of complete remissions and prolonged progression-free survival among patients with EGFR activating mutations”, Radiology and Oncology, 48(4). Available at: https://www.radioloncol.com/index.php/ro/article/view/2233 (Accessed: 18 April 2024).